10.66USD-3.35%Mkt Cap: 1.75B USDP/E: —Last update: 2026-06-01
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company comme…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.75B USD
Enterprise Value1.31B USD
Revenue (TTM)596.34M USD
Gross Profit1.05B USD
Net Income (TTM)440.30M USD
Revenue/Share3.669 USD
Last Price10.66 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees749
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6700024010
Valuation
P/E (Trailing)—
P/E (Forward)-20.22
PEG1.32
EV/EBITDA21.98
EV/Revenue2.19
P/S3.02
P/B-13.96
EPS (TTM)-0.56
EPS (Forward)-0.54
52W Range
6.13078% of range11.97
52W High11.97 USD
52W Low6.130 USD
Profitability
Gross Margin93.50%
Oper. Margin-7.19%
EBITDA Margin9.98%
Profit Margin39.19%
ROE-344.65%
ROA37.42%
Growth
Revenue Growth-79.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-244.63M USD
CapEx (TTM)6.39M USD
FCF Margin9.82%
FCF Yield3.34%
Net Debt-495.27M USD
Net Debt/EBITDA-8.32
Balance Sheet
Debt/Equity-1.95
Current Ratio2.48
Quick Ratio2.38
Book Value/Sh-0.7860 USD
Cash/Share4.806 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMay 10, 2019
Splits
Last Split1:20
Split DateMay 10, 2019
Analyst Consensus
Rating—
Target (Mean)14.11 USD
Target Range7.000 USD – 25.00 USD
# Analysts9
Ownership
Shares Out.164.44M
Float141.47M
Insiders5.01%
Institutions69.56%
Short Interest
Short Ratio9.1d
Short % Float27.71%
Short % Out.27.54%
Shares Short45.28M
Short (prev mo.)46.34M
Technical
SMA 508.828 (+20.8%)
SMA 2008.380 (+27.3%)
Beta2.37
S&P 52W Chg27.94%
Avg Vol (30d)5.22M
Avg Vol (10d)5.50M
Technical Indicators
RSI (14)64.7
MACD0.4780
MACD Signal0.2881
MACD Hist.+0.1899
BB Upper11.11 USD
BB Middle9.385 USD
BB Lower7.655 USD
BB Width36.86%
ATR (14)0.6970 USD
Vol Ratio (20d)0.75x